Peter Morgan Kash
Director/Board Member bei HEAE CAPI
Profil
Peter Morgan Kash is the founder of Arno Therapeutics, Inc. (founded in 2000) and Targimmune Therapeutics AG (founded in 2016).
He is currently the Chairman & President of Riverbank Capital Securities, Inc., a Director of Kirax Corp., Danube Pharmaceuticals, Inc., Cancer Schmancer Foundation, Fran Dreschers Organization, Keren Or, Inc., and President of Two River Group Management LLC.
He is also the Managing Director of FFD, Inc. (since 2017) and an Independent Director of Healthcare Capital Corp.
(Delaware) (since 2021).
Dr. Kash's former positions included Vice Chairman of Javelin Pharmaceuticals, Inc. and Velcera Pharmaceuticals, Inc., Senior Managing Director of Paramount BioCapital, Inc. (1992-2004), Director of Paramount BioCapital Asset Management, Inc., Intercept Pharmaceuticals, Inc., Arno Therapeutics, Inc., ID Vaccine Corp., and Nile Therapeutics, Inc., and Independent Director of Capricor Therapeutics, Inc. He was also a Partner at Two River Group Holdings LLC and General Partner of Orion Biomedical Fund LP.
Dr. Kash's education includes a doctorate from Yeshiva University, an undergraduate degree from State University of New York at Binghamton, and an MBA from Lubin School of Business.
Dr. Kash is also the founder of PolaRx Biopharmaceuticals, Andorra International, Inc., Keryx Biopharmaceuticals, Inc., and Firebrick Pharma Ltd.
Aktive Positionen von Peter Morgan Kash
| Unternehmen | Position | Beginn |
|---|---|---|
| HEAE CAPI | Director/Board Member | 20.01.2021 |
| Keren Or, Inc. | Director/Board Member | 27.11.2009 |
FFD, Inc.
 FFD, Inc. Packaged SoftwareTechnology Services FFD, Inc. provides manufacturing software solutions. The private company is based in Knoxville, TN. | Corporate Officer/Principal | 01.09.2017 |
Targimmune Therapeutics AG
 Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Founder | 01.01.2016 |
Kirax Corp.
 Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL. | Director/Board Member | 23.03.2011 |
| Two River Group Management LLC | President | 23.06.2010 |
| Fran Dreschers Organization | Director/Board Member | 27.11.2009 |
| Cancer Schmancer Foundation | Director/Board Member | 27.11.2009 |
Danube Pharmaceuticals, Inc.
 Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY. | Director/Board Member | - |
| ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
Ehemalige bekannte Positionen von Peter Morgan Kash
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Peter Morgan Kash
| Yeshiva University | Doctorate Degree |
| State University of New York at Binghamton | Undergraduate Degree |
| Lubin School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| DARIOHEALTH CORP. | Health Technology |
| ARNO THERAPEUTICS, INC. | Health Technology |
| FIREBRICK PHARMA LIMITED | Health Technology |
| CAPRICOR THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 23 |
|---|---|
Paramount BioCapital Asset Management, Inc.
 Paramount BioCapital Asset Management, Inc. Investment ManagersFinance Founded in 1991 by Dr. Lindsay Rosenwald, Paramount BioCapital Asset Management, Inc. is a hedge fund manager located in New York City. The firm is a subsidiary of Paramount BioCapital, Inc. | Finance |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
Paramount BioCapital, Inc.
 Paramount BioCapital, Inc. Investment ManagersFinance Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States. | Finance |
Two River Group Holdings LLC
 Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | Finance |
Kirax Corp.
Kirax Corp. Pharmaceuticals: MajorHealth Technology Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL. | Health Technology |
Riverbank Capital Securities, Inc.
 Riverbank Capital Securities, Inc. Investment Banks/BrokersFinance Part of Two River Group Holdings LLC, Riverbank Capital Securities, Inc. deals securities. The private company is based in New York, NY. | Finance |
Danube Pharmaceuticals, Inc.
Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY. | Health Technology |
| Arno Therapeutics, Inc. /Old/ | Health Technology |
| Orion Biomedical Fund LP | |
PolaRx Biopharmaceuticals
 PolaRx Biopharmaceuticals Miscellaneous Commercial ServicesCommercial Services Part of Swedish Orphan Biovitrum AB, PolaRx Biopharmaceuticals is a private company that manufactures TriOxide drugs for the treatment of leukemia and other cancers. The company is based in New York, NY. The company was founded by Fred H. Mermelstein, Peter Morgan Kash, Raymond P. Warrell. PolaRx Biopharmaceuticals was acquired by CTI BioPharma Corp., part of Swedish Orphan Biovitrum AB from June 27, 2023 on January 13, 2000 for $17.50 million. | Commercial Services |
| Polytechnic University | Consumer Services |
Javelin Pharmaceuticals, Inc.
 Javelin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA. | Health Technology |
| Velcera Pharmaceuticals, Inc. /Old/ | Health Technology |
ID Vaccine Corp.
 ID Vaccine Corp. Medical SpecialtiesHealth Technology Part of GSK Plc, ID Vaccine Corp. develops gene-based disease testing and subunit vaccines. | Health Technology |
| Nile Therapeutics, Inc. /Old/ | Health Technology |
| Two River Group Management LLC | |
| Cancer Schmancer Foundation | |
| Fran Dreschers Organization | |
| Keren Or, Inc. | |
Andorra International, Inc.
 Andorra International, Inc. Pharmaceuticals: OtherHealth Technology Andorra International, Inc. formulates, and manufactures and distributes dietary supplements. The firm offers Resveratrol, Caviar Omega, CholesteRight, Advanced Blood and Advanced Liver Detox products. The company was founded by Michelle Sun and Peter M. Kash in 2015 and is headquartered in Los Angeles, CA. | Health Technology |
Targimmune Therapeutics AG
Targimmune Therapeutics AG Pharmaceuticals: MajorHealth Technology Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland. | Health Technology |
FFD, Inc.
FFD, Inc. Packaged SoftwareTechnology Services FFD, Inc. provides manufacturing software solutions. The private company is based in Knoxville, TN. | Technology Services |
Healthcare Capital Corp. (Delaware)
 Healthcare Capital Corp. (Delaware) Financial ConglomeratesFinance Healthcare Capital Corp. operates as a blank check company. It engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on August 18, 2020 and is headquartered in Wilmington, DE. | Finance |
